Introduction
Methods
Study Instrument
Data Analysis
Results
Demographics of Respondents
Characteristics | N (%) |
---|---|
Age, years (mean ± SD) | 35.33 ± 12.94 |
Ethnicity | |
Malay | 19 (19.8) |
Chinese | 67 (69.8) |
Indian | 9 (9.4) |
Other | 1 (1.0) |
Years after graduation (basic degree) (n = 95) | |
< 5 years | 29 (30.5) |
5–10 years | 19 (20.0) |
> 10 years | 47 (49.5) |
Role in pharmacy | |
Owner | 23 (24.0) |
Manager | 12 (12.5) |
Full time pharmacist | 39 (40.6) |
Locum pharmacist | 27 (28.5) |
Type of pharmacy (n = 94) | |
Chain | 33 (35.1) |
Independent | 61 (64.9) |
Personal history of mental illness | |
Yes | 3 (3.1) |
No | 88 (91.7) |
Preferred not to answer | 5 (5.2) |
History of mental illness in a family member/close friend | |
Yes | 25 (26.0) |
No | 64 (66.7) |
Preferred not to answer | 7 (7.3) |
Knowledge level on mental disorders | |
Good | 34 (37.4) |
Fair | 49 (53.8) |
Poor | 8 (98.8) |
Belief that own opinions and beliefs about mental disorders would affect their ability to provide PC to these patients | |
Definitely | 20 (20.8) |
Probably | 27 (28.1) |
Maybe | 23 (24.0) |
Not at all | 18 (18.8) |
Don’t know | 8 (8.3) |
Stocking and Pharmaceutical Care Services
Statement | Disagree, N (%) | Neither agree nor disagree, N (%) | Agree, N (%) |
---|---|---|---|
(a) Because mentally ill patients have unpredictable behaviour and are aggressive; and as such I’d rather not deal with them | 11 (37.9) | 8 (27.6) | 10 (34.5) |
(b) I fear for my life and as a result I’d rather not deal with these patients | 16 (55.2) | 7 (24.1) | 6 (20.7) |
(c) Fear of social drug-related complications | 9 (31.0) | 10 (34.5) | 10 (34.5) |
(d) I feel uncomfortable stocking psychiatric medications for fear of being robbed (n = 28) | 15 (53.6) | 7 (25.0) | 6 (21.4) |
(e) Numerous medical legal issues | 3 (10.3) | 6 (20.7) | 20 (69.0) |
(f) Tough regulations of record keeping as required by law | 4 (13.8) | 4 (13.8) | 21 (72.4) |
(g) Unfamiliar with psychotropics | 12 (41.4) | 11 (37.9) | 6 (20.7) |
(h) Unfamiliar with mental disorders | 5 (17.2) | 13 (44.8) | 11 (37.9) |
(i) Few requests (n = 28) | 3 (10.7) | 8 (28.6) | 17 (60.7) |
(j) Determined by parent company/boss/manager (n = 28) | 7 (25.0) | 11 (39.3) | 10 (35.7) |
Statement | N (%) |
---|---|
Frequency of prescription requests for psychotropics | |
Daily | 2 (2.1) |
Two to three times | 7 (7.3) |
Once a week | 22 (22.9) |
Once a month | 22 (22.9) |
Once in 3–6 months | 28 (29.2) |
Once a year | 7 (7.3) |
Never | 8 (8.3) |
Gender of the majority of patients with prescription requests for psychotropics | |
Male | 31 (32.3) |
Female | 15 (15.6) |
Equal | 30
(31.3) |
Age group of the majority of patients with prescription requests for psychotropics | |
18–29 | 3 (3.1) |
30–39 | 12 (12.5) |
40–49 | 30 (31.3) |
50–59 | 25 (26.0) |
60–69 | 16 (16.7) |
70–79 | 1 (1.0) |
Average number of psychotropics sold a month (n = 61) | |
0 | 26 (42.6) |
1 | 7 (11.5) |
2 | 5 (8.2) |
3 | 11 (18.0) |
4 | 1 (1.6) |
5 | 6 (9.8) |
> 5 | 5 (8.2) |
Pharmaceutical care services provided to patients with mental disordersa | |
Counseling | 58 (60.4) |
Dispensing of drugs | 45 (46.9) |
Provision of drug information | 37 (38.5) |
Monitoring for side effects | 16 (16.7) |
Monitoring for adherence | 10 (10.4) |
Solving drug-related problems | 12 (12.5) |
None | 24 (25.0) |
Monitoring of efficacy | 7 (7.3) |
Frequency of providing drug counseling to patients, or relatives of patients with mental disorders | |
Daily | 1 (1.0) |
Two to three times | 4 (4.2) |
Once a week | 8 (8.3) |
Once a month | 22 (22.9) |
Once in 3–6 months | 34 (35.4) |
Never | 27 (28.1) |
Psychotropics being stocked (n = 719) | |
Antidepressants | |
SSRIs | 139 (19.3) |
TCAs | 69 (9.6) |
SNRIs | 30 (4.2) |
Others | 98 (13.6) |
Antipsychotics | |
Atypicals | 107 (14.9) |
Typicals | 48 (6.8) |
Anxiolytic | |
Benzodiazepines | 30 (4.2) |
Others | 40 (5.6) |
Drugs for bipolar disorder/antimanicb | 146 (20.3) |
Perception and Level of Comfort of Pharmacists in Managing Mental Disorders
Statement | Mean (± SD) | Disagree, N (%) | Neither agree nor disagree, N (%) | Agree, N (%) |
---|---|---|---|---|
(a) I find patients with mental disorders easily approachable (n = 95) | 2.78 (0.84) | 33 (34.7) | 45 (47.4) | 17 (17.9) |
(b) Handling of patients with mental disorders is easier compared to patients with other diseases (n = 94) | 2.46 (0.77) | 51 (54.3) | 35 (37.2) | 8 (8.5) |
(c) Mental illness is nothing to be ashamed of (n = 94) | 4.04 (0.83) | 6 (6.4) | 12 (12.8) | 76 (80.9) |
(d) All patients with mental disorders are potentially dangerous to the people around them (n = 95) | 3.26 (0.93) | 42 (44.2) | 29 (30.5) | 24 (25.3) |
(e) I am not afraid of patients with mental disorders (n = 93) | 3.22 (0.81) | 18 (19.4) | 38 (40.9) | 37 (39.8) |
(f) Patients with mental disorders do not want to talk to a pharmacist about their mental health symptoms (n = 95) | 2.99 (0.88) | 28 (29.5) | 37 (38.9) | 30 (31.6) |
Statement | Mean (± SD) | Disagree, N (%) | Neither agree nor disagree, N (%) | Agree, N (%) |
---|---|---|---|---|
(a) I find it easy to deal with relapse and non-adherence in patients with mental disorders (n = 95) | 2.57 (0.79) | 41 (43.2) | 45 (47.4) | 9 (9.5) |
(b) I have an interest in providing pharmaceutical care to patients with mental disorders (n = 94) | 3.30 (0.84) | 17 (18.1) | 35 (37.2) | 42 (44.7) |
(c) I have enough knowledge on the pharmacotherapy of patients with mental disorders (n = 94) | 2.78 (0.81) | 34 (36.2) | 44 (46.8) | 16 (17.0) |
(d) I feel confident enough to provide pharmaceutical care to patients with mental health problems (n = 93) | 3.19 (0.89) | 19 (20.4) | 38 (40.9) | 36 (38.7) |
(e) I feel comfortable enough to provide pharmaceutical care to patients with mental health problems (n = 94) | 3.35 (0.92) | 18 (19.1) | 27 (28.7) | 49 (52.1) |
(f) There is enough motivation for me to provide pharmaceutical care to patients with mental disorders (n = 95) | 3.16 (0.90) | 22 (23.2) | 40 (42.1) | 33 (34.7) |
(g) I feel comfortable asking patients their reason(s) for using psychotropics (n = 95) | 3.43 (0.81) | 15 (15.8) | 28 (29.5) | 52 (54.7) |
(h) I feel comfortable discussing the symptoms of mental illness with patients (n = 95) | 3.37 (0.89) | 16 (16.8) | 29 (30.5) | 50 (52.6) |
(i) I received adequate education/training about mental health during my undergraduate pharmacy education (n = 95) | 2.83 (1.01) | 38 (40.0) | 30 (31.6) | 27 (28.4) |
Perceived Barriers in Providing Pharmaceutical Care to Patients with Mental Disorders
Statement | Disagree, N (%) | Neither agree nor disagree, N (%) | Agree, N (%) | RIWF | Rank |
---|---|---|---|---|---|
(a) Lack of knowledge about mental disorders (n = 92) | 23 (25.0) | 24 (26.1) | 45 (48.9) | 0.692 | 1 |
(b) Patients do not understand pharmaceutical care (n = 93) | 8 (8.6) | 28 (30.1) | 57 (61.3) | 0.690 | 2 |
(c) Lack of training in pharmaceutical care practice (n = 92) | 13 (14.1) | 28 (30.4) | 51 (53.1) | 0.660 | 6 |
(d) Insufficient staff (n = 89) | 20 (22.5) | 23 (25.8) | 46 (51.7) | 0.613 | 8 |
(e) Lack of communication skills (n = 92) | 39 (42.4) | 31 (33.7) | 22 (23.9) | 0.542 | 14 |
(f) Lack of drug information sources (n = 90) | 45 (50.0) | 25 (27.8) | 20 (22.2) | 0.504 | 16 |
(g) Lack of documentation skills (n = 92) | 30 (32.6) | 34 (37.0) | 28 (30.4) | 0.571 | 13 |
(h) Lack of demand from patients (n = 92) | 14 (15.2) | 26 (28.3) | 52 (56.5) | 0.671 | 5 |
(i) Lack of private space/counseling area (n = 90) | 27 (30.0) | 22 (24.4) | 41 (45.6) | 0.598 | 11 |
(j) Lack of encouragement from head office/manager (n = 91) | 27 (29.7) | 39 (42.9) | 25 (27.5) | 0.541 | 15 |
(k) Lack of initiative (n = 92) | 22 (23.9) | 39 (42.4) | 31 (33.7) | 0.604 | 10 |
(l) Legal requirements (n = 92) | 15 (16.3) | 24 (26.1) | 53 (57.6) | 0.685 | 3 |
(m) Fear or discomfort of dealing with psychiatric patients (n = 91) | 30 (33.0) | 28 (30.8) | 33 (36.3) | 0.579 | 12 |
(n) Patient factors associated with their symptoms e.g. cognitive dysfunction, hostility, inattentiveness, irritability (n = 92) | 20 (21.7) | 38 (41.3) | 34 (37.0) | 0.606 | 9 |
(o) Time constraints (n = 92) | 21 (22.8) | 20 (21.7) | 51 (55.4) | 0.646 | 7 |
(p) Lack of patient information e.g. drug indication, treatment goals, etc. (n = 92) | 14 (15.2) | 22 (23.9) | 56 (60.9) | 0.675 | 4 |